Sarda Proteins Fair Value

Average Fair Value
₹28.73
Current Market Price: ₹97.78
-70.62% Price Difference

Sarda Proteins (SRDAPRT) average fair value is ₹28.73 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹97.78 (-70.62%), fair value range ₹6.67–₹61.91. Check Sarda Proteins marketcap in USD to track the company's total market size over time.

Fair Value Analysis Export

SRDAPRT Fair Value vs Current Price — Valuation Summary

SRDAPRT average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Sarda Proteins stock price NSE.

Average Fair Value
₹28.73
Current Market Price
₹97.78
Price Difference
₹-69.05
Percentage Difference
-70.62%
Fair Value Range
₹6.67 - ₹61.91
Methods Used
3
Analysis based on 3 valuation methods: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation

P/B Based Valuation

Book Value/Share ₹6.67
Sector Avg P/B 3.78
Historical Avg P/B N/A
Average Fair Value
₹17.6

Price-to-Sales Valuation

Revenue/Share ₹20.64
Sector Avg P/S 3.0
Fair Value
₹61.91

Asset-Based Valuation

Book Value/Share ₹6.67
Liquidation Value/Share ₹7.0
Fair Value
₹6.67

SRDAPRT Fair Value Analysis — Data Sources & Coverage

Sarda Proteins financial data sources, valuation methods applied and sector benchmarks used.

Methods Used
3
Sector
FMCG

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

SRDAPRT vs FMCG Sector Peers — P/E, P/B & Market Cap

Sarda Proteins P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Swasth Foodtech SWASTH -6.76 0.45 ₹9
Patanjali Foods PATANJALI 20.22 2.8 ₹37,099
Shreeji Global FMCG SHETHJI - 3.03 ₹347
Kwality Walls KWIL -26.8 11.8 ₹7,655
Evexia Lifecar EVEXIA 159.0 0.55 ₹304

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.